Sandoz is well-positioned for leadership in the fast-growing respiratory market given our strong portfolio and capabilities. At Sandoz, it is our purpose to improve the quality of treatment for asthma and chronic obstructive pulmonary disease (COPD), and to ease the suffering that seasonal allergies cause. The debilitating effects of airway constriction affect more than just the psychological and physical well-being of the individual patient. It is in fact a public health issue that comes at considerable socio-economic cost. That is why we at Sandoz draw on our strong Novartis heritage to create innovative products that improve the patient experience.
At the heart of our commitment is our Center of Excellence in Rudolstadt, Germany – a state-of-the-art, multi-platform development and manufacturing facility that houses an immense amount of expertise. It is in large part due to this high-tech facility that Sandoz has been able to build such a robust pipeline of differentiated respiratory products that improve patient lives.